2Mobini R, Maschke H, Waagstein F. New insights into the pathogenesis of dilated cardiomyopathy: possible underlying autoimmune mechanisms and therapy. Autoimmun Rev 2004;3(4):277-284.
3Schwimmbeck PL, Badorff C, Rohn G, et al. The role of sensitized T-cells in myocarditis and dilated cardiomyopathy. Int J Cardiol 1996;54(2):117-125.
4Rakozy CK, Mohamed AV, Vo TD, et al. CD56^+/CD4^+ lymphomas and leukemias are morphologically, innumophenotypocally, cytogenetically and clinically diverse. Am J Clin Pathol 2001;116(2):168-176.
5Richardson CP, Mckenna RM, Bristow CM, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathy. Circulation 1996;93:841-842.
6Staudt A, Staudt Y, Dorr M, et al. Potential role of humoral immunity in cardiac dysfunction of patients suffering from dilated cardiomyopathy. J Am Coll Cardiol 2004;44(4):829-836.
